Efficacy of an Occupational Time Use Intervention for People With Serious Mental Illness

NCT ID: NCT00520728

Last Updated: 2015-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-08-31

Study Completion Date

2008-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the efficacy of a new Occupational Time Use Intervention designed to increase activity participation and improve meaning in the lives of people with serious mental illness living in the community.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

5 Assertive Community Treatment (ACT) Teams from Kingston (n=2), Belleville (n=1), and Ottawa (n=2) will be involved in a 12 week randomized controlled trial of our Time Use Intervention. 20 subjects (4 subjects from each team) will participate in this pilot study and will be treated individually by their ACT team Occupational Therapist (1 OT per ACT Team). This pilot test will help to determine the clinical utility and efficacy of our treatment protocol.

Comparison: Standard ACT treatment with the Occupational Time Use Intervention vs. Standard ACT treatment

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Serious Mental Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Experimental arm receives 12 week intervention along with standard care.

Group Type EXPERIMENTAL

Occupational Time Use Intervention

Intervention Type BEHAVIORAL

12 week behavioral intervention administered by Occupational Therapists.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Occupational Time Use Intervention

12 week behavioral intervention administered by Occupational Therapists.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (18-65 years of age);
* Primary diagnosis of a severe psychiatric disorder with a psychotic feature;
* Team and self-perceived occupational disengagement (low activity levels);
* Fluent in English;
* Living in a community setting and receiving ACT treatment;
* Own legal guardian (thus competent to give consent to participate), and are willing to give written informed consent to participate in the study.

Exclusion Criteria

* Unstable mental health;
* Lack of interest in a time use intervention;
* Satisfied with current time use and occupations;
* ACT Team Occupational Therapist is subject's main Case Manager.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Queen's University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Megan Edgelow

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Megan M Edgelow, MSc

Role: PRINCIPAL_INVESTIGATOR

Queen's University

Terry Krupa, PhD

Role: STUDY_DIRECTOR

Queen's University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OTUI1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brief Mood Enhancement Intervention
NCT02954965 COMPLETED NA
Wellness Self-Management
NCT01676909 COMPLETED NA